Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
Veru: On Right Track For FDA EUA Submission
03:45pm, Friday, 27'th May 2022
An Emergency Use Authorization submission of sabizabulin for high-risk hospitalized Covid-19 patients is expected Q2 of 2022. With EUA and then possibly NDA occurring for sabizabulin, Veru would be in
Veru Inc. Still Has Serious Growth To Realize
03:41am, Thursday, 19'th May 2022
Veru Inc is a Florida-based drug developer, which focuses primarily on developing cancer-treatment drugs as well as its sexual health division. This year, the company hit a stroke of luck upon discove
VERU Stock Alert: 6 Things to Know as Veru Appoints a New Executive
10:45am, Wednesday, 18'th May 2022
Veru (VERU) stock is on the move Wednesday following news of the biopharmaceutical company adding Joel Batten to its list of executives. The post VERU Stock Alert: 6 Things to Know as Veru Appoints a
So What's Up With Veru Shares Rising Today?
03:49pm, Tuesday, 17'th May 2022
Shares of companies in the broader consumer staples sector, including Veru Inc (NASDAQ: VERU), are trading higher as stocks rebound from recent weakness. Stocks have experienced volatility this year a
Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show Promise
12:37pm, Tuesday, 17'th May 2022
VERU stock's rapid upward trajectory could continue as Veru releases its fiscal results and marks a significant clinical milestone. The post Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show
Veru: Where Big Pharma Failed To Tread
09:23am, Tuesday, 17'th May 2022
Veru's Sabizabulin showed superlative results in critically ill COVID patients. No other drug has been able to achieve this.
Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022
08:30am, Tuesday, 17'th May 2022
MIAMI, May 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the m
5 Short Squeeze Candidates To Watch This Week: Vertex Energy Tops List, Medavail Holdings And Camping World Remain Elevated
11:38am, Monday, 16'th May 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Veru Inc.'s (VERU) CEO Mitchell Steiner on Q2 2022 Results - Earnings Call Transcript
12:20pm, Thursday, 12'th May 2022
Call End: Veru Inc. (NASDAQ:VERU ) Q2 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, Investor Relations and Corporate Communications Mitc
Veru Inc. (VERU) Reports Q2 Loss, Misses Revenue Estimates
09:02am, Thursday, 12'th May 2022
Veru Inc. (VERU) delivered earnings and revenue surprises of -12.50% and 14.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
VERU Stock Pops on a Covid-19 Treatment Milestone
10:09am, Wednesday, 11'th May 2022
Veru (VERU) stock is rising higher on Wednesday following a recent ruling from the FDA concerning the company's Covid-19 treatment. The post VERU Stock Pops on a Covid-19 Treatment Milestone appeared
Best Stocks To Buy Now? 5 Health Care Stocks In Focus
02:30pm, Monday, 09'th May 2022
Could these health care stocks be the remedy to investors' recent stock market pains?
Earnings Preview: Veru Inc. (VERU) Q2 Earnings Expected to Decline
04:33pm, Thursday, 05'th May 2022
Veru Inc. (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Veru Stock Plummeted on Monday
05:33pm, Monday, 02'nd May 2022
A short-seller makes some worrying accusations against the company.
Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop
11:22am, Monday, 02'nd May 2022
Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.
